Business

Husband and wife team Marie Pelton and Jim Victor have been making the Farm Show sculptures for years.

Here's a look at what's affected, what's being done about it, and whether you should worry.

The Delaware SPCA has announced a development plan for its site in Stanton. The first to be developed will house a Royal Farms convenience store and gas pumps.

Starting Jan. 1, Delawareans will pay five cents per fluid milliliter of e-juice — the often flavored liquid containing nicotine used to produce the vapor in e-cigarettes.

A new analysis found wealthy individuals and high-profit businesses in Pennsylvania and nine other states may make money when they donate to private school scholarships.

In 18 states and 20 localities, lawmakers are forcing up the minimum wage on Jan. 1.

The coffee giant selected Trenton as the ninth of 15 planned "opportunity cafes" — stores opened in underserved, low- to medium-income communities that train young workers.

The GOP tax overhaul is giving some nonprofit organizations holiday heartburn. The reason: itemization. More specifically, it’s the lack thereof.

Being “indie” once defined a creative project as not being backed by a major producer. It is a way of life, and it is ingrained in the spirit of the City of Brotherly Love.

Guest: Nir Eyal How often do you look at your smartphone during the day – checking Facebook or Twitter, or post ...

Confirming iPhone owners' suspicions that Apple purposefully slows the operation of older phones, Apple says that it does just that.

Beijing-based Seven Stars Cloud Group bought a 27 percent stake in the Delaware Board of Trade for an undisclosed amount.

The collaborative effort with Nuvve Corp. includes a research and development center to expand vehicle-to-grid technology pioneered at UD's Newark campus.

The Bucks County Republican says he's stepping down from the legislature to become executive director of the Philadelphia Parking Authority.

For Katherine High, president and chief scientific officer at Spark Therapeutics, the drug’s approval signals renewed hope in the possibilities of gene therapy.